Codes / ICD10CM / T38.2

T38.2 Poisoning by, adverse effect of and underdosing of antithyroid drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by, adverse effect of and underdosing of antithyroid drugs

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to antithyroid drugs. These medications are used to treat hyperthyroidism, and the code covers clinical scenarios where their use leads to harmful outcomes or insufficient therapeutic effect.

Causes

The causes include accidental or intentional overdose of antithyroid drugs, adverse reactions to prescribed or non-prescribed use, or inadequate dosing that fails to achieve the intended therapeutic effect. Underdosing may result from missed doses, incorrect administration, or subtherapeutic prescribing.

Risk Factors

  • Use of antithyroid drug therapies for hyperthyroidism
  • Polypharmacy involving antithyroid agents
  • Incorrect dosing or administration
  • Individual sensitivity to antithyroid substances
  • Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific agent and scenario: poisoning may cause hypothyroidism (e.g., fatigue, weight gain, cold intolerance); adverse effects can include allergic reactions or organ-specific toxicity; underdosing may lead to unresolved hyperthyroidism (e.g., tachycardia, tremors, heat intolerance).

Diagnosis

Diagnosis relies on a thorough medication history, clinical assessment of symptoms, and laboratory tests to evaluate thyroid function and drug levels. Documentation should specify the type of antithyroid drug involved and the nature of the event (poisoning, adverse effect, or underdosing).

Treatment Options

Treatment depends on the severity and type of event. For poisoning, decontamination or supportive care may be necessary. Adverse effects may require discontinuation of the drug or symptom management. Underdosing typically involves adjusting the dose or regimen to achieve therapeutic goals.

Prognosis and Follow-Up

Prognosis varies based on the extent of exposure and timely intervention. Regular follow-up is essential to monitor thyroid function and adjust treatment as needed. Long-term outcomes depend on the resolution of the underlying thyroid disorder and management of any complications.

Complications

Complications can include severe hypothyroidism or hyperthyroidism, organ damage from toxicity, or treatment failure due to underdosing. Prompt recognition and management are critical to minimize risks.

Lifestyle & Prevention

Patients should adhere to prescribed dosing schedules and avoid self-adjusting medications. Regular monitoring of thyroid function and education on drug interactions can help prevent adverse events or underdosing.

When to Seek Professional Help

Seek immediate medical attention for symptoms of severe hypothyroidism or hyperthyroidism, such as chest pain, difficulty breathing, or altered mental status. Contact a healthcare provider for persistent or worsening symptoms related to antithyroid drug use.

Tips for Medical Coders

When coding T38.2, ensure documentation specifies the antithyroid drug involved and the nature of the event (poisoning, adverse effect, or underdosing). Include details on the clinical presentation and any contributing factors to support accurate code assignment.

Book a walkthrough

T38.2 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.